Drug resistance in tuberculosis-a reinfection model

Theoretical Population Biology

Volumn 71, Issue 2, 2007, Pages 196-212

  Rodrigues, Paula ^a,b   Gomes, M Gabriela M ^a   Rebelo, Carlota ^c  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Coexistence; Control strategies; Drug resistance; Mathematical models; Reinfection; Stability; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

BACTERIUM; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TRANSMISSION; DRUG RESISTANCE; EPIDEMIOLOGY; IMMUNITY; NUMERICAL MODEL; TUBERCULOSIS;

ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; RECURRENT DISEASE; THEORETICAL MODEL; TREATMENT FAILURE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MODELS, THEORETICAL; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33846596636     PISSN: 00405809     EISSN: 10960325     Source Type: Journal    
DOI: 10.1016/j.tpb.2006.10.004     Document Type: Article

References (32)

1. Austin D.J., Kakehashi M., and Anderson R.M. The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc. R. Soc. London B 264 (1997) 1629-1638
2. Blower S.M., and Chou T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nature Med. 10 (2004) 1111-1116
3. Blower S.M., and Gerberding J. Understanding, predicting and controlling the emergence of drug tuberculosis: a theoretical framework. J. Mol. Med. 76 (1998) 624-636
4. Blower S.M., Small P.M., and Hopewell P.C. Control stretagies for tuberculosis epidemics: new models for old problems. Science 273 5274 (1996) 497-500
5. Bonhoeffer S. Managing antibiotic resistance: what models tell us. In: Dieckmann U., Metz J.A.J., Sabelis M.W., and Sigmund K. (Eds). Adaptive Dynamics and Infectious Diseases: "In Pursuit of Virulence Management" (2002), Cambridge University Press, Cambridge, UK 326-338
6. Boni M.F., and Feldman M.W. Evolution of antibiotic resistance by human and bacterial niche construction. Evolution 59 3 (2005) 477-491
7. Breban R., and Blower S. The reinfection threshold does not exist. J. Theor. Biol. 235 (2005) 151-152
8. Castillo-Chavez C., and Feng Z. To treat or not to treat: the case of tuberculosis. J. Math. Biol. 35 (1997) 629-656
9. Caswell H. Matrix Population Models: Construction, Analysis, and Interpretation (2001), Sinauer Ass., Sunderland, MA, US
10. Chiang C.Y., and Riley L.W. Exogenous reinfection in tuberculosis. Lancet Infect. Dis. 5 (2005) 629-636
11. Cohen T., and Murray M. Modelling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature Med. 10 (2004) 1117-1121
12. Cohen T., Sommers B., and Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect. Dis. 3 (2003) 13-21
13. Crofton, J., Chaulet, P., Mahaler, D., 1997. Guidelines for the management of drug resistant tuberculosis. WHO/TB/96.21 (Rev/1) p. 8.
14. Dhooge A., Govaerts W., and Kuznettsov Y.A. Matcont: a Matlab package for numerical bifurcation analysis of ODE's. ACM Trans. Math. Software 29 (2003) 141-164
15. Dye C., and Espinal M.A. Will tuberculosis become resistant to all antibiotics?. Proc. R. Soc. London B 268 (2001) 45-52
16. Dye C., and Williams B.G. Criteria for the control of drug-resistant tuberculosis. Proc. Natl. Acad. Sci. USA 97 (2000) 8180-8185
17. Dye C., Garnett G.P., Sleeman K., and Williams B.G. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. The Lancet 352 (1998) 1886-1891
18. Dye C., Williams B., Espinal M.A., and Raviglione M. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295 (2002) 2042-2046
19. Espinal M.A., et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. J. Am. Med. Assoc. 283 19 (2000) 2537-2545
20. Gagneux S., long D.C., Small P., Van T., Schoolnik G.K., and Bohannan B.J.M. The competitive cost of antibiotic resistance in Mycobaterium tuberculosis. Science 312 (2006) 1944-1946
21. Gomes M.G.M., Franco A.O., Gomes M.C., and Medley G.F. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc. R. Soc. London B 271 (2004) 617-623
22. Gomes M.G.M., White L.J., and Medley G.F. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J. Theor. Biol. 235 2 (2004) 151-152
23. Gomes M.G.M., White L.J., and Medley G.F. The reinfection threshold. J. Theor. Biol. 236 (2005) 111-113
24. Gomes, M.G.M., Paulo, A., Rodrigues, R., Hilker, F., Mantilla-Beniers, N.B., Muehlen, M., Medley, G. 2006. The potential of post-exposure interventions in global tuberculosis control, submitted for publication.
25. Pablos-Méndez A., Gowda D.K., and Friedman T.R. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull. WHO 80 6 (2002) 489-495
26. van den Driessche P., and Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180 (2002) 29-48
27. van Rie A., Richardson M., Johnson R., van der Spuy G.D., Murray E.J., Beyers N., van Pittius N.C., van Helden P.D., and Warren R.M. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am. J. Respir. Crit. Care Med. 172 5 (2004) 636-642
28. Vynnycky E., and Fine P.E. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol. Infect. 1619 2 (1997) 183-201
29. Warren R.M., Victor C.T., Streicher M.E., Richardson M., Beyers N., van Pittius N.C., and van Helden P.D. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169 (2004) 610-614
30. WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance, 1998. Guidelines for surveillance of drug resistance in tuberculosis, WHO Geneva/IUATLD, Paris. Int. J. Tuberc. Lung Dis. 2, 72-89.
31. WHO/IUATLD, 2004. Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World: third global report, WHO/HTM/TB/2004.343.
32. World Health Organization 2005. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2005.349, Geneve.